Equity Method Investment (Tables)

12 Months Ended

Dec. 31, 2024

Equity Method Investment

Schedule of financial information of Angel Pharmaceuticals Co.

Summary financial information for Angel is as follows:

		As of		As of
Balance Sheet Data	December 31, 2024		December 31, 2023
	(in thousands)
Current assets	$	12,957	$	17,628
Non-current assets		1,316		1,427
Current liabilities		1,202		1,725
Non-current liabilities		593		648
Stockholders' equity		12,478		16,682

	Year Ended December 31,
Statement of Operations Data	2024		2023		2022
	(in thousands)
Revenue	$	—	$	—	$	—
Gross Profit		—		—		—
Net income (loss)		(3,783)		(6,213)		(11,846)
Share of loss from investments accounted for using the equity method		(3,197)		(5,284)		(10,005)